212
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997–2008

&
Pages 214-219 | Received 01 Oct 2013, Accepted 14 Jan 2014, Published online: 16 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David M. Wood, Roumen Sedefov, Andrew Cunningham & Paul I. Dargan. (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology 53:2, pages 85-92.
Read now
S. Srisuma, E. J. Lavonas & W. Wananukul. (2014) Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors. Clinical Toxicology 52:7, pages 674-677.
Read now

Articles from other publishers (6)

Jennifer V. Robblee, Richard J. ButterfieldA. Min Kang & Jonathan H. Smith. (2020) Triptan and ergotamine overdoses in the United States. Neurology 94:14.
Crossref
Ahmed Badawy, Mohamed Darwich & Ali Aqeel. (2018) Case 1: The Impact of Methylergometrin Maleate Toxicity on Neonates. NeoReviews 19:12, pages e762-e764.
Crossref
Taija Liisa Somppi. (2017) Non-Thyroidal Illness Syndrome in Patients Exposed to Indoor Air Dampness Microbiota Treated Successfully with Triiodothyronine. Frontiers in Immunology 8.
Crossref
Bryan M. Corbett, Charles O\'Connell, Mallory A. Boutin, Nabil I. Fatayerji & Charles W. Sauer. (2016) Inadvertent Methylergonovine Administration to a Neonate. American Journal of Case Reports 17, pages 770-773.
Crossref
. (2015) Methylergometrine overdose. Reactions Weekly 1566:1, pages 158-158.
Crossref
Franca Davanzo, Laura Settimi, Felice Giordano, Maria Luisa Casini & Fernanda Ferrazin. (2015) Inadvertent oral administration of methylergometrine maleate to children in the first months of life: from surveillance to prevention. Pharmacoepidemiology and Drug Safety 24:3, pages 269-275.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.